Navigation Links
Orexigen® Therapeutics Presents Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
Date:10/3/2011

d reinforces the robustness of the results."

An oral presentation by Gene-Jack Wang, MD, Chair of Brookhaven Laboratory's Medical Department, will outline neuroimaging data from a clinical study conducted in collaboration with Brookhaven National Laboratory.  Changes in brain response to food cues with Contrave or placebo treatment were assessed using functional MRI imaging and showed that Contrave enhanced the activation of brain regions involved in inhibitory control, internal awareness, memory and cognition following exposure to food cues.  These results further support the postulated mechanism by which Contrave may help patients control food cravings.

In addition, new analyses from the COR-I and COR-BMOD Phase 3 studies will be presented.  On average 34% and 17% of patients in COR-I receiving Contrave therapy for 1 year achieved weight loss milestones of >/=10 or >/=15%, respectively.  This level of weight loss translates to losing 60-73% of excess body weight, which is in the range reported for surgical procedures such as gastric banding.

About Contrave

Contrave, an investigational combination therapy of naltrexone HCl SR and bupropion HCl SR, was studied for its ability to help people with obesity initiate and sustain weight loss of at least 5 percent of their starting body weight in one year.  Contrave was submitted for U.S. regulatory approval in March 2010.  The original submission was based on multiple clinical trials that evaluated Contrave in more than 4500 patients.  Orexigen received a Complete Response letter from FDA on January 31, 2011.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave has completed Phase 3 clinical trials, and the Company's other product candidate, Empatic(TM), has completed Phase 2 clinical trials. Further information about the Company can be f
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
(Date:5/21/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... , the company,s vice president of operations, was granted an ... at a per share exercise price of $0.43, the closing ... granted pursuant to Cardica, Inc.,s Inducement Plan, which was approved ... Rule 5653(c)(4) of the Nasdaq Global Market for equity grants ...
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... following statement regarding the Medicare Part D offsets ... Century Cures initiative: "If the 21st Century ... billions from America,s premier health program – Medicare ... it may yield down the road. ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Cardica Announces New Employment Inducement Grant 2
(Date:5/23/2015)... 23, 2015 On Wednesday, May 20, ... company has been the target of a sophisticated cyberattack,” ... the company’s ongoing Information Technology (IT) security efforts in ... , The most notable attack on health insurers was ... the nation’s second largest health insurer, revealed that they ...
(Date:5/23/2015)... 23, 2015 Manufacturers are now required to ... (HSPF) of 8.2. Experts in the field agree that the ... , The HSPF score is what miles per gallon is ... the unit. Although the minimum HSPF score has been raised ... an HSPF score north of 12. Indeed, the regulation was ...
(Date:5/23/2015)... WI (PRWEB) May 23, 2015 ... Acceleration at the Sports Medicine and Rehabilitation Center, 557 ... clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. , ... USAT coach, and Laurie Finke, RN, BSN, who will ... exercises, education on nutrition, running mechanics and show selection ...
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on ... Maryland legislature but which has not been signed to date ... HB 449 with overwhelming bipartisan support on April 10, ... law. This bill ensures that fracking is prohibited in Maryland ... danger of fracking to our water supplies and the air ...
(Date:5/22/2015)... May 22, 2015 Pioneer Millworks, the ... the forefront of designing with reclaimed wood, introducing their ... Los Angeles, California. Their newest offerings, Vat 35, ... surface and color to America's largest design event. , ... at each show, anxious to see and feel the ...
Breaking Medicine News(10 mins):Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... International Union files anti-SLAPP motion against,the California ... stunt, OAKLAND, Calif., April 21 ... an anti-Strategic Lawsuit,to Prevent Public Participation motion ... the union from further efforts to silence,critics ...
... According to researchers at The University of Texas M. ... cancer screening and early detection, has shown to significantly ... breast cancer in women over the age of 80, ... screenings. , The study, published online today ...
... Mich., April 21 /PRNewswire-FirstCall/ .- Perrigo Company,(Nasdaq: ... filed an Abbreviated New,Drug Application (ANDA) for over-the-counter ... a generic version of Monistat(R) 1,Combination Pack. The ... file an ANDA,with a Paragraph IV certification against ...
... (Jack) F. Smith Jr. to Retire: Kenneth I. Chenault Appointed to Board ... ... Company (NYSE: PG ) today announced that John (Jack) F. Smith (70),will ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/pg/32757/ ...
... using a tray saves water and energy; reduces food waste, ... on,300 college campuses served by Sodexo will line up to ... plastic tray. The move was introduced by Sodexo,as part of ... trayless saves thousands of gallons of water each day,and reduces ...
... MDS Board, TORONTO, April 21 /PRNewswire-FirstCall/ - MDS ... and services to the global life,sciences markets, today announced ... William Dempsey, former Executive Vice-President,of Abbott Laboratories, have been ... both Greg and Bill and look forward to benefiting ...
Cached Medicine News:Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 3Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 4Health News:Mammography may be beneficial to all women, regardless of age 2Health News:Mammography may be beneficial to all women, regardless of age 3Health News:Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack 2Health News:Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack 3Health News:Procter & Gamble Announces Board Changes 2Health News:Sodexo Challenges Diners on College Campuses to Go Trayless and Go Green 2Health News:MDS Appoints Two New Directors 2Health News:MDS Appoints Two New Directors 3
... The visco-elastic ENDOGEL is a ... sodium hyaluronate. ENDOGEL is supplied in ... with a Luer-Lock fitting, delivering 0,85 ... linear polysaccharide composed of repetitive chains ...
... is designed to provide excellent protection and ... advantage of being closer to an adhesive ... This allows CoEase to maintain viscosity at ... of both worlds for superb performance during ...
... sterile, nonpyrogenic, viscoelastic preparation of a ... fraction of sodium hyaluronate., ,Healon contains ... in physiological sodium chloride phosphate buffer ... polymer is made up of repeating ...
... device is a highly retentive, dispersive ... molecular weight, low pseudoplasticity and low ... maintenance and excellent tissue protection. It ... size (catalog number 8065183905) or as ...
Medicine Products: